Sais e Derivados de API
Os sais dos Ingredientes Farmacêuticos Ativos (API) são compostos formados pela reação de um ácido com uma base, resultando em um equilíbrio iônico. Esses sais frequentemente melhoram a solubilidade e a estabilidade dos APIs, facilitando sua absorção no organismo. Os derivados de API são variantes químicas de um princípio ativo que podem apresentar propriedades aprimoradas ou modificadas para otimizar a eficácia terapêutica. Os sais de APIs são utilizados na formulação de medicamentos orais, injetáveis e tópicos. Além disso, os derivados de API podem melhorar a farmacocinética dos fármacos, permitindo, por exemplo, a liberação controlada de substâncias ativas.
Na CymitQuimica, oferecemos sais e derivados de APIs com a pureza e qualidade necessárias para pesquisa e desenvolvimento de formulações farmacêuticas.
Foram encontrados 79383 produtos de "Sais e Derivados de API"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Verapamil Related Compound B (4-[(3,4-Dimethoxyphenethyl)(methyl)amino]-2-(3,4-dimethoxyphenyl)-2-isopropylbutanenitrile hydrochloride)
CAS:Nitrile function compounds, nesoiFórmula:C26H36N2O4·HClCor e Forma:White Crystalline PowderPeso molecular:440.26751Depramine (3-(5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride)
Anti-infective agents, nesoiFórmula:C19H22N2Cor e Forma:Yellow PowderPeso molecular:278.1783Urea Related Compound A (Dicarbonimidic diamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFórmula:C2H5N3O2Cor e Forma:White PowderPeso molecular:103.03818Dermatan Sulfate
CAS:Natural polymers & modified natural polymers, in primary forms, nesoiCor e Forma:White PowderPeso molecular:Average 46275Fludeoxyglucose Related Compound B (2-chloro-2-deoxy-D-glucose)
CAS:Heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C6H11ClO5Cor e Forma:White Off-White PowderPeso molecular:198.0295Gadodiamide Related Compound A (Gadolinium sodium diethylenetriamine pentaacetic acid monomethylamide)
CAS:Compounds, inorganic or organic, of rare-earth metals, of yttrium or of scandium, or of mixtures of these metals, nesoi (excluding cerium compounds)Fórmula:C15H22GdN4NaO9Cor e Forma:White Off-White Pale Yellow PowderPeso molecular:583.05256Famciclovir Related Compound F (2-Amino-6-chloropurine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C5H4ClN5Cor e Forma:Light Yellow Off-White PowderPeso molecular:169.01552Medroxyprogesterone Acetate Related Compound B (17-Hydroxy-6α-methylpregn-4-ene-3,20-dione)
CAS:Estrogens and progestinsFórmula:C22H32O3Cor e Forma:White PowderPeso molecular:344.23514Adapalene Related Compound C (2-(adamant-1-yl)methoxybenzene)
CAS:Aromatic ethers and their halogenated, sulfonated, nitrated or nitrosated derivativesFórmula:C17H22OCor e Forma:PowderPeso molecular:242.16707Iohexol Related Compound C (N,N'-Bis(2,3-dihydroxypropyl)-5-nitro-1,3- benzenedicarboxamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C14H19N3O8Cor e Forma:White PowderPeso molecular:357.11721Diclofenac Sodium
CAS:Aromatic amino-acids and their esters,other than thoseFórmula:C14H11Cl2NO2·NaCor e Forma:PowderPeso molecular:318.00645Ketorolac Related Compound D (5-benzoyl-2,3-dihydro-1H-pyrrolizine)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C14H13NOCor e Forma:White Light Brown PowderPeso molecular:211.09971Iohexol Related Compound B (5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C14H18I3N3O6Cor e Forma:Off-White SolidPeso molecular:704.83298Escitalopram Related Compound A ((S)-4-[4-dimethylamino-1-(4-fluoropheny)-1-hydroxy-1-butyl]-3-hydroxymethylbenzonitrile hemi(+)-di-toluoyltartrate)
CAS:Nitrile function compounds, not elsewhere specified orFórmula:C20H23FN2O2C20H18O8Cor e Forma:PowderPeso molecular:342.17436Moxifloxacin Related Compound D (1-Cyclopropyl-8-fluoro-6-methoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)
CAS:Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFórmula:C21H24FN3O4Cor e Forma:Yellow SolidPeso molecular:401.17508Furosemide Related Compound A (2-Chloro-4-N-furfurylamino-5-sulfamoylbenzoic Acid)
CAS:Sulfonamides, nesoiFórmula:C12H11ClN2O5SCor e Forma:White Off-White PowderPeso molecular:330.00772Cloxacillin Related Compound D (3-(2-Chlorophenyl)-5-methylisoxazole-4-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C11H8ClNO3Cor e Forma:PowderPeso molecular:237.01927Bendamustine Related Compound D (4-{5-[(2-Chloroethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoic acid hydrochloride)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C14H18ClN3O2HClCor e Forma:Pink SolidPeso molecular:332.23Proguanil Related Compound D (1,5-bis(1-methylethyl)biguanide hydrochloride)
CAS:Non-aromatic imines and their derivatives; salts thereof, nesoiFórmula:C8H19N5·HClCor e Forma:White Crystalline PowderPeso molecular:185.16405Eszopiclone Related Compound A (6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo [3,4,b] pyrazin-5-yl 4-methylpiperazine-1-carboxylate 4-oxide)
CAS:Lactams not elsewhere specified or includedFórmula:C17H17ClN6O4Cor e Forma:Off-White PowderPeso molecular:404.09998o-Iodohippuric Acid
CAS:Aromatic cyclic amides (including cyclic carbamates) anFórmula:C9H8INO3Cor e Forma:PowderPeso molecular:304.95489Racemic Tamsulosin Hydrochloride
CAS:Sulfonamides, nesoiFórmula:C20H28N2O5S·HClCor e Forma:White CrystalsPeso molecular:408.17189Galantamine Hydrobromide Related Compounds Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:White PowderRoflumilast Related Compound D (3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFórmula:C12H12F2O4Cor e Forma:Yellow White PowderPeso molecular:258.07037Ethyl 3-Aminocrotonate (Ethyl (Z)-3-aminobut-2-enoate)
CAS:Amino-acids (excluding aromatic) and their esters other than those containing more than one kind of oxygen function, nesoiFórmula:C6H11NO2Cor e Forma:Colorless Pale Yellow Liquid At Room TemperaturePeso molecular:129.07898Repaglinide Related Compound B (3-Ethoxy-4-ethoxycarbonylphenylacetic acid)
CAS:Carboxylic acids with additional oxygen function and thFórmula:C13H16O5Cor e Forma:PowderPeso molecular:252.09977Oxymetholone Related Compound B (17β-Hydroxy-1-hydroxymethylene-17α-methyl-5α-androstan-3-one)
CAS:Ketone-alcohols and ketone-aldehydes, nesoiFórmula:C21H32O3Cor e Forma:Off-White Light Yellow SolidPeso molecular:332.235142,3-Dimethylaniline
CAS:Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFórmula:C8H11NCor e Forma:Clear Yellow Amber Red Brown LiquidPeso molecular:121.08915Buspirone Related Compound L (8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione)
CAS:Imides and their derivatives (excluding sacharin), salt thereofFórmula:C13H20ClNO2Cor e Forma:Colorless Clear Light Yellow LiquidPeso molecular:257.11826Rivastigmine Related Compound B ((R,S)-3-[1-(Dimethylamino)ethyl]phenyl dimethylcarbamate)
CAS:Aromatic cyclic amides (including cyclic carbamates) anFórmula:C13H20N2O2Cor e Forma:Yellow LiquidPeso molecular:236.15248Fosinopril Related Compound E ((4S)-4-Phenyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-L-proline propionate (ester), sodium salt)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C30H39NNaO7PCor e Forma:White PowderPeso molecular:579.23618Azelastine Related Compound F (4-[4-(4-Chlorobenzyl)-1-oxophthalazin-2(1H)-yl]-1-methylazepane 1-oxide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C22H24ClN3O2Cor e Forma:White SolidPeso molecular:397.1557Leflunomide Related Compound A (4-(trifluoromethyl)aniline)
CAS:Toluidines (aminotoluenes) and their derivatives, salts thereofFórmula:C7H6F3NCor e Forma:White Light Yellow LiquidPeso molecular:161.04523Iopamidol Related Compound C (4-chloro-N1, N3-bis(1,3-dihydroxypropan-2-yl)-5-(S)-lactamido-2,6-diiodoisophthalamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C17H22ClI2N3O8Cor e Forma:White PowderPeso molecular:684.91849Indomethacin Related Compound B (4-Chlorobenzoic acid)
CAS:Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives, nesoiFórmula:C7H5ClO2Cor e Forma:White Off-White PowderPeso molecular:155.99781Zonisamide Related Compound C (N'-(benzisoxazol-3-ylmethylsulfonyl)-N,N-dimethylformimidamide)
CAS:Sulfonamides, nesoiFórmula:C11H13N3O3SCor e Forma:White SolidPeso molecular:267.3Deferasirox Related Compound F (4-Hydrazinylbenzoic acid)
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFórmula:C7H8N2O2Cor e Forma:Yellow Orange Brown PowderPeso molecular:152.05858Verapamil Related Compound E (3,4-dimethoxybenzaldehyde)
CAS:Aldehyde-ethers, aldehyde-phenols and aldehydes with otFórmula:C9H10O3Cor e Forma:PowderPeso molecular:166.06299Carteolol Related Compound F (5-(2-Hydroxy-3-methoxypropoxy)-3,4-dihydroquinolin-2(1H)-one)
CAS:Lactams not elsewhere specified or includedFórmula:C13H17NO4Cor e Forma:White Off-White PowderPeso molecular:251.11576Phenylbutyrate Related Compound C (4-cyclohexylbutanoic acid)
CAS:Cyclanic, cyclenic or cycloterpenic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivativesFórmula:C10H18O2Cor e Forma:White PowderPeso molecular:170.13068Estradiol Related Compound B (1,3,5(10),6-estratetraen-3,17β-diol)
CAS:Estrogens and progestinsFórmula:C18H22O2Cor e Forma:White Yellow Crystalline PowderPeso molecular:270.16198Azacitidine Related Compound C (1-β-D-Ribofuranosyl-3-guanylurea picrate)
CAS:Sugars, chemically pure, other than sucrose, lactose, maltose, glucose and fructose; sugar ethers and sugar esters, and their salts, nesoiFórmula:C7H14N4O5·C6H3N3O7Cor e Forma:Yellow PowderPeso molecular:234.09642Lisinopril Related Compound A ((S)-2-{(3S,8aS)-3-(4-aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-α]pyrazin-2(1H)-yl}-4-phenylbutanoic acid)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C21H29N3O4Cor e Forma:Yellow Off-White Crystalline PowderPeso molecular:387.21581Prochlorperazine Related Compound A (4-Chloro-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine dihydrochloride)
CAS:Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFórmula:C20H24ClN3S·2HClCor e Forma:Light Grey PowderPeso molecular:373.13795Dimenhydrinate Related Compound E (8-chloro-3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFórmula:C8H9ClN4O2Cor e Forma:White Off-White PowderPeso molecular:228.0414Paliperidone Related Compound A (3-Ethyl-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-α]pyrimidin-4-one)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C11H16N2O2Cor e Forma:Off-White PowderPeso molecular:208.12118Dipyridamole Related Compound F (2,2',2'',2'''-({4-[(2-Hydroxyethyl)amino]-8-(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl}bis(azanetriyl))tetraethanol)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C21H36N8O5Cor e Forma:SolidPeso molecular:480.28087Beclomethasone Dipropionate Related Compound A (9-Chloro-11β,17-dihydroxy-16β-methyl-3,20-dioxopregna-1,4-diene-21-yl propionate)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFórmula:C25H33ClO6Cor e Forma:White Off-White PowderPeso molecular:464.19657Triamterene Related Compound B (2,7-diamino-4-hydroxy-6-phenylpteridine)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFórmula:C12H10N6OCor e Forma:Light Yellow Crystalline PowderPeso molecular:254.09161Amoxicillin Related Compound B (L-amoxicillin)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H19O5N3SCor e Forma:PowderPeso molecular:365.10454Phenytoin Related Compound B (2,2-Diphenyl-2-ureidoacetic acid)
CAS:Ureines and their derivatives; salts thereofFórmula:C15H14N2O3Cor e Forma:White PowderPeso molecular:270.10044Dexmedetomidine Related Compound C (5-[1-(2,3-Dimethylphenyl)ethyl]-1-ethyl-1H-imidazole)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C15H20N2Cor e Forma:White SolidPeso molecular:228.16265Betamethasone Dipropionate Related Compound B (9-Fluoro-11β,21-dihydroxy-16β-methyl-3,20-dioxopregna-1,4-diene-17-yl propionate)
CAS:Halogenated derivatives of adrenal cortical hormonesFórmula:C25H33FO6Cor e Forma:White PowderPeso molecular:448.22612Dalfampridine Related Compound C (1,3-Di(pyridin-4-yl)urea)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C11H10N4OCor e Forma:White SolidPeso molecular:214.08546Molindone Related Compound A (3-Ethyl-2-methyl-1,5,6,7-tetrahydro-4H-indol-4-one)
CAS:Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFórmula:C11H15NOCor e Forma:Off-White PowderPeso molecular:177.11536Nitazoxanide Related Compound A (5-Nitrothiazole-2-amine)
CAS:Compounds containing an unfused thiazole ring (whetherFórmula:C3H3N3O2SCor e Forma:Yellow PowderPeso molecular:145.15 g/molAlmotriptan Related Compound C (N-methyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine)
CAS:Aromatic or modified aromatic drugs with nitrogen heteroFórmula:C16H23N3O2SCor e Forma:SolidPeso molecular:321.1511Zidovudine Related Compound C (thymine)
CAS:Compounds containing a pyrimidine ring (whether or notFórmula:C5H6N2O2Cor e Forma:PowderPeso molecular:126.04293Trisalicylic Acid
CAS:Esters of salicylic acid and its salts not elsewhere specified or includedFórmula:C21H14O7Cor e Forma:White PowderPeso molecular:378.07395Ethyl Benzoate
CAS:Benzoic acid, its salts and estersFórmula:C9H10O2Cor e Forma:Colorless LiquidPeso molecular:150.06808Nateglinide Related Compound C (N-(cis-4-isopropylcyclohexanecarbonyl)-D-phenylalanine)
CAS:Aromatic cyclic amides (including cyclic carbamates) anFórmula:C19H27NO3Cor e Forma:White PowderPeso molecular:317.42Irinotecan Related Compound E ((S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFórmula:C22H20N2O4Cor e Forma:Light Brown PowderPeso molecular:376.14231Piroxicam Related Compound A (Pyridin-2-amine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C5H6N2Cor e Forma:Yellow SolidPeso molecular:94.0531Verapamil Related Compound F ((3,4-Dimethoxyphenyl)methanol)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFórmula:C9H12O3Cor e Forma:Colorless Light Yellow Clear Liquid ViscousPeso molecular:168.07864Abacavir Related Compounds Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:PowderCefprozil (Z)-Isomer
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C18H19N3O5S·H2OCor e Forma:PowderPeso molecular:389.10454N-Ethylpiperazine
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFórmula:C6H14N2Cor e Forma:Colorless LiquidPeso molecular:114.1157Nifedipine Nitrophenylpyridine Analog (Dimethyl 4-(2-nitrophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H16N2O6Cor e Forma:White Yellow PowderPeso molecular:344.10084Benazepril Related Compound C ((S)-2-{[(S)-1-(Carboxymethyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl]amino}-4-phenylbutanoic acid)
CAS:Lactams, nesoiFórmula:C22H24N2O5Cor e Forma:White Clumpy PowderPeso molecular:396.16852Quazepam Related Compound A (7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-one)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C17H11ClF4N2OCor e Forma:Off-White Cream PowderPeso molecular:370.0496Benzalkonium Chloride (5 mL of approx. 4% aqueous solution)
CAS:<p>Cationic organic surface-active agents,other than aromatic or modified aromatic, whether or not for retail sale</p>Cor e Forma:Clear Colorless LiquidAzaerythromycin A (9-Deoxo-9a-aza-9a-homoerythromycin A)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C37H70N2O12Cor e Forma:White PowderPeso molecular:734.49288Nicotine Related Compound B (3-(1-methyl-1H-pyrrol-2-yl)pyridine)
CAS:Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFórmula:C10H10N2Cor e Forma:Colorless Light Yellow Oily LiquidPeso molecular:158.0844Norgestimate Related Compound A (Levonorgestrel acetate)
CAS:Estrogens and progestinsFórmula:C23H30O3Cor e Forma:White Off-White PowderPeso molecular:354.21949Carbidopa Related Compound A (3-O-Methylcarbidopa)
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFórmula:C11H16N2O4Cor e Forma:Yellow Tan PowderPeso molecular:240.11101Dabigatran Etexilate Related Compound B (Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate 4-toluenesulfonate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C27H29N7O3·C7H8O3SCor e Forma:White Yellow PowderPeso molecular:671.77Rivaroxaban Related Compound H ((S)-4,5-Dichloro-N-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H17Cl2N3O5SCor e Forma:Yellow PowderPeso molecular:469.0266Benzophenone (Diphenylmethanone)
CAS:Aromatic ketones without other oxygen function, nesoiFórmula:C13H10OCor e Forma:Colorless White Crystalline Powder CrystalsPeso molecular:182.07316Dichlorothienoic Acid (4,5-dichlorothiophene-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C5H2Cl2O2SCor e Forma:Off-White SolidPeso molecular:195.91526Olopatadine Related Compound B ((Z)-3-{2-(carboxymethyl)dibenzo[b,e]oxepin-11(6H)-ylidene}-N,N-dimethylpropan-1-amine oxide)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C21H23NO4Cor e Forma:White PowderPeso molecular:353.16271Ketoprofen Related Compound F (3-(1-Cyanoethyl)benzophenone)
CAS:Nitrile function compounds, nesoiFórmula:C16H13NOCor e Forma:White Off-White PowderPeso molecular:235.09971Aminophenylmorpholin-2-one (4-(4-aminophenyl)morpholin-2-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C10H12N2O2Cor e Forma:Pale Yellow SolidPeso molecular:192.08988Quetiapine Related Compound G (Dibenzo[b,f][1,4]thiazepin-11(10H)-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C13H9NOSCor e Forma:White Off-White PowderPeso molecular:227.04049Tenofovir Disoproxil Related Compound G (O-(Isopropoxycarbonyloxymethyl)-O-isopropyl-{(R)-[1-(6-amino-9H-purin-9-yl)propan-2-yloxy]}methylphosphonate) fumarate)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C17H28N5O7P·C4H4O4Cor e Forma:PowderPeso molecular:445.17264Metformin Related Compound B (1-Methylbiguanide hydrochloride)
CAS:Non-aromatic imines and their derivatives; salts thereof, nesoiFórmula:C3H9N5·HClCor e Forma:White PowderPeso molecular:115.0858Dofetilide
CAS:Sulfonamides used as drugsFórmula:C19H27N3O5S2Cor e Forma:White Off-White Crystalline PowderPeso molecular:441.13921Norgestrel Related Compound L (13-Ethylgon-4-ene-3,17-dione)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C19H26O2Cor e Forma:White SolidPeso molecular:286.19328Roflumilast Related Compound E (N-(3-Bromo-5-chloropyridin-4-yl)-3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H14BrClF2N2O3Cor e Forma:White Beige PowderPeso molecular:445.98444Rivaroxaban Related Compound D (1,3-Bis({(S)-2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)urea)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C29H32N6O9Cor e Forma:Off-White White SolidPeso molecular:608.22308Urea
CAS:Urea, whether or not in aqueous solutionFórmula:CH4N2OCor e Forma:White Powder CrystalsPeso molecular:60.03236Fosinopril Related Compound H (4-phenylbutyl phosphonic acid)
CAS:Organo-inorganic compounds, nesoiFórmula:C10H15O3PCor e Forma:White PowderPeso molecular:214.07588Argatroban Related Compound A ((2R,4R)-1-[N8-nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
CAS:Sulfonamides, nesoiFórmula:C23H31N7O7SCor e Forma:White PowderPeso molecular:549.20057p-Ranolazine (N-(2,6-Dimethylphenyl)-2-{4-[2-hydroxy-3-(4-methoxyphenoxy)propyl]piperazin-1-yl}acetamide)
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFórmula:C24H33N3O4Cor e Forma:White PowderPeso molecular:427.24711Pravastatin 1,1,3,3-Tetramethylbutylamine
CAS:Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFórmula:C23H36O7·C8H19NCor e Forma:White Crystalline Powder CrystalsPeso molecular:424.2461Zolmitriptan Related Compound B ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C15H23N3OCor e Forma:White SolidPeso molecular:261.18411Abacavir Stereoisomers Mixture
Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureCor e Forma:White Off-White PowderNorscopolamine ((1R ,2R ,4S ,5S ,7s )-3-Oxa-9-azatricyclo[3.3.1.0^2,4]nonan-7-yl (S)-3-hydroxy-2-phenylpropanoate)
CAS:Aromatic or modified aromatic heterocyclic compounds with nitrogen hetero atom(s) only, except acridine, indole and carbazoleFórmula:C16H19NO4Cor e Forma:White Off-White PowderPeso molecular:289.13141Etidronate Disodium Related Compound A (Sodium phosphite dibasic pentahydrate)
CAS:Phosphinates (hypophosphites) and phosphonates (phosphiFórmula:Na2HPO3·5H20Cor e Forma:White Waxy SolidPeso molecular:125.94587Imiquimod Related Compound C (4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C14H14ClN3Cor e Forma:White Crystalline PowderPeso molecular:259.08763Lansoprazole Related Compound A (2-({[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl}sulfonyl)benzimidazole)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C16H14F3N3O3SCor e Forma:White Crystalline PowderPeso molecular:385.0708Meclizine Related Compound A (4-Chlorobenzhydrol)
CAS:Compounds containing a pyrimidine ring (whether or notFórmula:C13H11ClOCor e Forma:White PowderPeso molecular:218.04984Nevirapine Related Compound A (5,11-dihydro-6H-11-ethyl-4-methyl-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFórmula:C14H14N4OCor e Forma:Light Yellow Off-White Crystalline PowderPeso molecular:254.11676Moxifloxacin Related Compound A (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFórmula:C20H21F2N3O3Cor e Forma:White Off-White PowderPeso molecular:389.1551Rivaroxaban N-acyl glycolic acid ((S)-2-(2-(5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)thiophene-2-carboxamido)ethoxy)acetic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C24H21Cl2N3O7S2Cor e Forma:Off-White SolidPeso molecular:597.0198Aprepitant Related Compound B (3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C23H21F7N4O3Cor e Forma:White Off-White Crystalline PowderPeso molecular:534.15019Moxifloxacin Related Compound B (1-Cyclopropyl-6,8-dimethoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate)
Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ringFórmula:C22H27N3O5·HCl·H2OCor e Forma:SolidPeso molecular:413.19507Amlodipine Related Compound K (Ethyl 6-(2-chlorophenyl)-8-methyl-3,4,6,7-tetrahydro-2H-benzo[b][1,4]oxazine-5-carboxylate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C18H18ClNO3Cor e Forma:PowderPeso molecular:331.09752Dacarbazine Related Compound A (5-aminoimidazole-4-carboxamide hydrochloride)
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFórmula:C4H6N4O·HClCor e Forma:White Off-White PowderPeso molecular:126.05416Fentanyl Related Compound D (N-Phenyl-1-(phenylmethyl)-4-piperidinamine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C18H22N2Cor e Forma:White Yellow PowderPeso molecular:266.1783Temozolomide Related Compound C (diphenylcarbamic chloride)
CAS:Aromatic cyclic amides (including cyclic carbamates) anFórmula:C13H10ClNOCor e Forma:PowderPeso molecular:231.04509Pioglitazone Hydrochloride
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C19H20N2O3S·HClCor e Forma:White PowderPeso molecular:356.11946Meclizine Related Compound B (1-[(4-Chlorophenyl)(phenyl)methyl]-4-(2-methylbenzyl)piperazine dihydrochloride monohydrate)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C25H27ClN2·2HCl·H2OCor e Forma:White PowderPeso molecular:390.18628Brimonidine Related Compound A (5-Bromoquinoxalin-6-amine)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C8H6BrN3Cor e Forma:Yellow Crystalline PowderPeso molecular:222.97451Citalopram Related Compound F (dimethyl-(1-methyl-3,3-diphenyl-allyl)-amine hydrochloride)
CAS:Aromatic monoamines and their derivatives, salts thereof, nesoiFórmula:C18H21N·ClHCor e Forma:White Crystalline PowderPeso molecular:287.144084-Methoxymeloxicam (4-methoxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C15H15N3O4S2Cor e Forma:Yellow PowderPeso molecular:365.0504Atenolol Related Compound B (2-[4-(2,3-Dihydroxypropoxy)phenyl]acetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C11H15NO4Cor e Forma:White PowderPeso molecular:225.10011Phenylephrine Related Compound E (2-[Benzyl(methyl)amino]-1-(3-hydroxyphenyl)ethan-1-one hydrochloride)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C16H17NO2·HClCor e Forma:Grey To White PowderPeso molecular:291.10261Valacyclovir Related Compound G (N,N-dimethylpyridin-4-amine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C7H10N2Cor e Forma:White CrystalsPeso molecular:122.0844Dronedarone Related Compound B ((5-Amino-2-butylbenzofuran-3-yl){4-[3-(dibutylamino)propoxy]phenyl}methanone, dihydrochloride)
CAS:Aromatic pesticides with oxygen heteroFórmula:C30H42N2O3·2HClCor e Forma:SolidPeso molecular:550.2729Nitrofurazone Related Compound A (1,2-Bis[(5-nitrofuran-2-yl)methylene]hydrazine)
CAS:Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure nesoiFórmula:C10H6N4O6Cor e Forma:Yellow PowderPeso molecular:278.02873Voriconazole Related Compound A ((2RS, 3RS)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C16H14F3N5OCor e Forma:Light Yellow PowderPeso molecular:349.11504Nicotine Related Compound A (1,2,3,6-tetrahydro-2,3'-bipyridine)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFórmula:C10H12N2Cor e Forma:Pale Yellow Light Brown LiquidPeso molecular:160.10005Cyclosporine Resolution Mixture (This material is an approximate 100:1 (w/w) mixture of cyclosporine and cyclosporine U)
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:White PowderOrlistat Related Compound C (Triphenylphosphine Oxide)
CAS:Non-halogenated organo-phosphorous derivatives, nesoiFórmula:C18H15OPCor e Forma:White Beige PowderPeso molecular:278.08605Sulconazole Related Compound A (1-[2-(4-Chlorobenzyl)sulfinyl-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate)
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFórmula:C18H15Cl3N2OS·HNO3Cor e Forma:PowderPeso molecular:474.99271Melamine (2,4,6-Triamino-1,3,5-triazine)
CAS:MelamineFórmula:C3H6N6Cor e Forma:White Crystalline PowderPeso molecular:126.06539Iopromide Related Compound A (5-Amino-N1,N3-Bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-N1-methylisophthalamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C15H20I3N3O6Cor e Forma:White Crystalline PowderPeso molecular:718.84863Adapalene Related Compound D (4,4'-dimethoxy-3,3'-di(adamant-1-yl)biphenyl)
CAS:Aromatic ethers and their halogenated, sulfonated, nitrated or nitrosated derivativesFórmula:C34H42O2Cor e Forma:PowderPeso molecular:482.31848Amantadine Related Compound B (N-(Adamantan-1-yl)acetamide)
CAS:Cyclic amides and their derivatives, nesoiFórmula:C12H19NOCor e Forma:White PowderPeso molecular:193.14666Fluoxetine Related Compound C (4-(methyl{3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl}amino)-4-oxobutanoic acid)
Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C21H22F3NO4Cor e Forma:PowderPeso molecular:409.41Eplerenone Related Compound F ( Sodium 9,11α-Epoxy-17-hydroxy-7α-(methoxycarbonyl)-3-oxo-17α-pregn-4-ene-21-carboxylate)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFórmula:C24H31NaO7Cor e Forma:Light Yellow SolidPeso molecular:454.196751,3-Dinitroglycerin
CAS:Esters of other inorganic acids of nonmetals & their salts, their halogenated/sulfonated/nitrated/nitrosated derivs, except of hydrogen halides, nesoiFórmula:C3H6N2O7Cor e Forma:Clear Colorless LiquidPeso molecular:182.0175Tiagabine Related Compound A ((R)-ethyl 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylate, hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C22H29NO2S2·HClCor e Forma:White PowderPeso molecular:440.07Doxazosin Related Compound G (4-Amino-6,7-dimethoxyquinazolin-2(1H)-one hydrochloride)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C10H11N3O3·HClCor e Forma:White PowderPeso molecular:257.05672Apixaban
CAS:Lactams, nesoiFórmula:C25H25N5O4Cor e Forma:Off-White White SolidPeso molecular:459.19065Bisoprolol Related Compound C (1-(Isopropylamino)-3-(4-methylphenoxy)propan-2-ol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFórmula:C13H21NO2Cor e Forma:White SolidPeso molecular:223.15723Flutamide Related Compound A (4-nitro-3-(trifluoromethyl)aniline)
CAS:Toluidines (aminotoluenes) and their derivatives, salts thereofFórmula:C7H5F3N2O2Cor e Forma:PowderPeso molecular:206.03031Rivaroxaban Phthalimido Analog ((R)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl) isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C21H21N3O5Cor e Forma:White Off-White SolidPeso molecular:395.14812Lanolin Alcohols
CAS:Wool grease, except crude, and fatty substances derivedCor e Forma:Pale Yellow Brownish Yellow Waxy SolidN-Demethylazithromycin
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C37H70N2O12Cor e Forma:White PowderPeso molecular:734.49288Fluorouracil Related Compound A (Pyrimidine-2,4,6(1H,3H,5H)-trione)
CAS:Malonylurea (barbituric acid) and its saltsFórmula:C4H4N2O3Cor e Forma:White PowderPeso molecular:128.02219Trazodone Related Compound D (2-{3-[4-(3-Bromophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C19H22BrN5O·HClCor e Forma:White Crystalline PowderPeso molecular:415.10077Methyl 2-chloro-β-D-phenylalanine (methyl (R)-2-amino-2-(2-chlorophenyl)acetate, hydrochloride)
CAS:Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, nesoiFórmula:C9H10ClNO2·HClCor e Forma:White Off-White SolidPeso molecular:235.01668Cetirizine Related Compound C (2-(2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethoxy)acetamide)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C21H26ClN3O2Cor e Forma:PowderPeso molecular:387.17135Metformin Related Compound C (N,N-Dimethyl-[1,3,5]triazine-2,4,6-triamine)
CAS:Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFórmula:C5H10N6Cor e Forma:White Off-White PowderPeso molecular:154.09669Pitavastatin Related Compound A (Calcium (3SR,5SR,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate)
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFórmula:CaC25H23FNO4Cor e Forma:White Off-White Fine PowderPeso molecular:880.28481Glycopyrrolate Related Compound B (1-Methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate Hydrochloride)
CAS:Aromatic polycarboxylic acids, their anhydrides, halideFórmula:C18H25NO3Cor e Forma:Off-White PowderPeso molecular:339.86Acetylcysteine Related Compound D (N,S-Diacetyl-L-Cysteine)
CAS:Other organo-sulfur acid compoundsFórmula:C7H11NO4SCor e Forma:White SolidPeso molecular:205.04088Amlodipine Related Compound F (Dimethyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate maleate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C19H23ClN2O5·C4H4O4Cor e Forma:Off-White PowderPeso molecular:394.12955Ziprasidone Related Compound B (5-{2-[4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloroindoline-2,3-dione)
CAS:Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fusedFórmula:C21H19ClN4O2SCor e Forma:Dark Yellow PowderPeso molecular:426.92Rivaroxaban Glycolic Acid Analog ((S)-2-(2-((4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)amino)ethoxy)acetic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H20ClN3O6SCor e Forma:Pale Yellow SolidPeso molecular:453.07613Entacapone Related Compound A ((Z)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide)
CAS:Nitrile function compounds, nesoiFórmula:C14H15N3O5Cor e Forma:Dark Orange PowderPeso molecular:305.10117Triacetin
CAS:Esters of acetic acid not elsewhere specified or includedFórmula:C9H14O6Cor e Forma:Colorless Oily LiquidPeso molecular:218.21Metformin Hydrochloride
CAS:Non-aromatic imines and their derivatives; salts thereof, nesoiFórmula:C4H11N5·HClCor e Forma:White Off-White PowderPeso molecular:129.10145Carisoprodol Related Compound A (2-hydroxymethyl-2-methylpentyl carbamate)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFórmula:C8H17NO3Cor e Forma:White PowderPeso molecular:175.12084Flutamide Related Compound B (N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C9H7F3N2O3Cor e Forma:PowderPeso molecular:248.04088Ropinirole Related Compound A (4-(2-hydroxyethyl)indolin-2-one)
CAS:Lactams not elsewhere specified or includedFórmula:C10H11NO2Cor e Forma:Light Yellow PowderPeso molecular:177.07898Iopamidol Related Compound B (N1,N3-Bis(1,3-dihydroxypropan-2-yl)-5-(2-hydroxyacetamido)-2,4,6-triiodoisophthalamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C16H20I3N3O8Cor e Forma:White PowderPeso molecular:763.06Rivaroxaban Phthalimide ((S)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C21H21N3O5Cor e Forma:White Off-White SolidPeso molecular:395.14812Timolol Related Compound C (N-(tert-Butyl)-2,3-bis(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-1-amine maleate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H31N7O4S2·C4H4O4Cor e Forma:White Off-White PowderPeso molecular:601.19885Atomoxetine Related Compound A (3-(Methylamino)-1-phenylpropan-1-ol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFórmula:C10H15NOCor e Forma:White Off-White Light Yellow PowderPeso molecular:165.11536Vecuronium Bromide Related Compound C (Piperidinium, 1-[(2β,3α,5α,16β,17β)-3,17-dihydroxy-2-(1-piperidinyl) androstan-16-yl]-1-methyl bromide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C30H53BrN2O2Cor e Forma:White Off-White PowderPeso molecular:552.32904Metaraminol Related Compound A ((E)-1-[3-(benzyloxy)phenyl]-2-(hydroxyimino)propan-1-one)
CAS:Aromatic imines and their derivatives, salts thereofFórmula:C16H16NO3Cor e Forma:Off-White SolidPeso molecular:270.11302Nimodipine Related Compound A (2-methoxyethyl-1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C21H24N2O7Cor e Forma:LiquidPeso molecular:416.15835Diphenhydramine N-Oxide (2-(benzhydryloxy)-N,N-dimethylethan-1-amine oxide hydrochloride)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C17H21NO2·HClCor e Forma:PowderPeso molecular:307.13391Efavirenz Related Compound A ((S)-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFórmula:C13H11NOF3ClCor e Forma:White PowderPeso molecular:289.04813Sumatriptan Succinate Related Compound C ([3-[2-(dimethylamino)ethyl]-1-(hydroxymethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide succinate salt)
CAS:Sulfonamides, nesoiFórmula:C15H23N3O3S(C4H6O4)Cor e Forma:Off-White PowderPeso molecular:384.47Travoprost Related Compound A ((Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-{(R,E)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl}cyclopentyl)hept-5-enoic acid)
CAS:Prostaglandins, thromboxanes and leukotrienes, their deFórmula:C23H29F3O6Cor e Forma:Colorless LiquidPeso molecular:458.19162Valproic Acid Related Compound B ((2RS)-2-(1-methylethyl)pentanoic acid)
CAS:Saturated acyclic monocarboxylic acids and their anhydrides, halides, peroxides etc, nesoiFórmula:C8H16O2Cor e Forma:Colorless Pale Yellow LiquidPeso molecular:144.11503Theophylline Related Compound B (3-Methyl-1H-purine-2,6-dione)
CAS:Theophylline and aminophylline (excluding fenetylline) and their derivatives, salts thereof, not elsewhere specified or includedFórmula:C6H6N4O2Cor e Forma:Light Yellow PowderPeso molecular:166.04908Inamrinone Related Compound B (2-Hydroxy-N-(6-oxo-1,6-dihydro-[3,4'-bipyridin]-5-yl)propanamide)
Lactams not elsewhere specified or includedFórmula:C13H13N3O3Cor e Forma:Tan PowderPeso molecular:259.09569Guanylmelamine Dinitrate (1-(4,6-diamino-1,3,5-triazin-2-yl)guanidine, nitrate)
CAS:Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFórmula:C4H8N8·2HNO3Cor e Forma:Off-White SolidPeso molecular:168.08719Verteporfin Related Compound A ((+/-)18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-23H,25H-benzo[b]prophine-9,13-dipropanoic acid)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFórmula:C40H40N4O8Cor e Forma:Dark Green PowderPeso molecular:704.77Triclosan Related Compounds Mixture A
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:Colorless Clear LiquidClarithromycin Impurity D (N-desmethyl clarithromycin)
CAS:Lactones nesoiFórmula:C37H67NO13Cor e Forma:White Off-White PowderPeso molecular:733.46124Diclofenac Related Compound A (N-(2,6-dichlorophenyl)indolin-2-one)
CAS:Lactams not elsewhere specified or includedFórmula:C14H9Cl2NOCor e Forma:Beige PowderPeso molecular:278.14Glipizide Related Compound B (6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide)
CAS:Sulfonamides, nesoiFórmula:C14H16N4O3SCor e Forma:White PowderPeso molecular:320.09431Clonidine Related Compound C (Methyl N'-(2,6-dichlorophenyl)carbamimidothioate)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Fórmula:C8H8Cl2N2SCor e Forma:Light Orange Yellow Light Brown PowderPeso molecular:233.97852Clarithromycin Impurity H (3""-N-Demethyl-3""-N-formyl-6-O-methylerythromycin A)
CAS:Lactones nesoiFórmula:C38H67NO14Cor e Forma:White PowderPeso molecular:761.45616Metaxalone Related Compound C (Bis[2-hydroxy-3-(3,5-dimethylphenoxy)propyl]amine)
CAS:Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFórmula:C22H31NO4Cor e Forma:White PowderPeso molecular:373.49Diazepam Related Compound B (3-Amino-6-chloro-1-methyl-4-phenylcarbostyril)
CAS:Lactams, nesoiFórmula:C16H13ClN2OCor e Forma:Pale Yellow PowderPeso molecular:284.07164Acetaminophen Related Compound A (4-(acetylamino)phenyl acetate)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C10H11NO3Cor e Forma:White PowderPeso molecular:193.07389Pramipexole Related Compound F ((6S,7R)-2-Amino-6-(propylamino)-4,5,6,7-tetrahydrobenzothiazol-7-ol)
CAS:Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fusedFórmula:C10H17N3OSCor e Forma:Off-White SolidPeso molecular:227.10923Metformin Related Compound A (1-Cyanoguanidine)
CAS:1-cyanoguanidine (dicyandiamide)Fórmula:C2H4N4Cor e Forma:White PowderPeso molecular:84.1Bromperidol Decanoate
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C31H41BrFNO3Cor e Forma:PowderPeso molecular:573.22538Norfloxacin Related Compound A (7-Chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C12H9ClFNO3Cor e Forma:White PowderPeso molecular:269.0255Piroctone Related Compound A ((2-[5-methyl-3-(2,4,4-trimethylpentyl)-4,5-dihydroisoxazol-5-yl]acetic acid) 2-aminoethanol salt)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H32N2O4Cor e Forma:Brown LiquidPeso molecular:316.44Ecamsule Related Compound C (terephthalic acid)
CAS:Terephthalic acid and its saltsFórmula:C8H6O4Cor e Forma:White Off-White SolidPeso molecular:166.13Repaglinide Related Compound E ((R)-2-Ethoxy-4-[2-({3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C27H36N2O4Cor e Forma:PowderPeso molecular:452.26751Ketorolac Related Compound A (5-Benzoyl-N-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-2,3-dihydro-1H-pyrrolizine-1-carboxamide)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C19H22N2O5Cor e Forma:White PowderPeso molecular:358.15287Gatifloxacin Related Compound E (1-Cyclopropyl-6-fluoro-8-methoxy-7-(2-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid monohydrochloride)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C19H22FN3O4·HClCor e Forma:SolidPeso molecular:411.13611Xanthone
CAS:Aromatic pesticides with oxygen hetero-atom(s) only neFórmula:C13H8O2Cor e Forma:White PowderPeso molecular:196.21Chloroquine Related Compound A (4,7-dichloroquinoline)
CAS:Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFórmula:C9H5Cl2NCor e Forma:Off-White Brownish Yellow CrystalsPeso molecular:196.9799N-Nitroso Diclofenac (2-(2-((2,6-dichlorophenyl) (nitroso)amino)phenyl)acetic acid)
CAS:Compounds with other nitrogen function, nesoiFórmula:C14H10Cl2N2O3Cor e Forma:Off-White PowderPeso molecular:324.00685Ethacrynic Acid Related Compound C ({4-[2-(4-(Carboxymethoxy)-2,3-dichlorobenzoyl)-2,5-diethyl-3,4-dihydro-2H-pyran-6-yl]-2,3-dichlorophenoxy}acetic acid)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C26H24Cl4O8Cor e Forma:Off-White PowderPeso molecular:604.02253Sulfamethoxazole Related Compound F (4-amino-N-(3-methylisoxazol-5-yl)benzenesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C10H11N3O3SCor e Forma:Off-White Yellow Fine PowderPeso molecular:253.05211Moxifloxacin Related Compound G (1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid, monohydrochloride)
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFórmula:C21H24FN3O4·HClCor e Forma:Yellow PowderPeso molecular:437.15176Formoterol Related Compound A (2-Amino-4-(1-hydroxy-2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenol)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C18H24N2O3Cor e Forma:Off-White Grey SolidPeso molecular:316.17869Diazepam Related Compound E (6-Chloro-1-methyl-4-phenylquinazolin-2(1H)-one)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C15H11ClN2OCor e Forma:Off-White PowderPeso molecular:270.05599
![Buspirone Related Compound L (8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1078824.webp&w=3840&q=75)
![Rivastigmine Related Compound B ((R,S)-3-[1-(Dimethylamino)ethyl]phenyl dimethylcarbamate)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1604870.webp&w=3840&q=75)
![Almotriptan Related Compound C (N-methyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}etha…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1013556.webp&w=3840&q=75)
![Repaglinide Related Compound E ((R)-2-Ethoxy-4-[2-({3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}ami…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1600868.webp&w=3840&q=75)